Novartis AG - H5820Q150
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | History | Reduced | 24,335 | 3,811 | 0.13% | 0.16% | 1 | -3,879 | -13.75% | Q2 2026 | Aug 13, 2026 |
| Generali Investments CEE, investicni spolecnost, a.s. | History | Reduced | 15,729 | 2,463 | 0.12% | 0.14% | 2 | -1,328 | -7.79% | Q2 2026 | Jul 13, 2026 |